Related Experiment Video
Updated: Mar 22, 2026

Drug-Induced Sleep Endoscopy DISE with Target Controlled Infusion TCI and Bispectral Analysis in Obstructive Sleep Apnea
Published on: December 6, 2016
Cephalometric risk factors associated with myocardial infarction in patients suffering from obstructive sleep apnea:
Zeinab Davoudmanesh1,2, Mohamad Bayat1,3, Mohsen Abbasi1,3
1a Craniomaxillofacial Research Center, Shariati Hospital , Tehran University of Medical Sciences , Tehran , Iran.
Introduction:
Obstructive sleep apnea (OSA) and its craniofacial anatomic risk factors might play a role in several cardiovascular diseases, including myocardial infarction (MI). However, there are no data about cephalometric findings among OSA patients with MI.
Methods:
In this pilot case-control study, about 2000 individuals referred to the sleep center were evaluated according to apnea - hypopnea index (AHI) and other inclusion criteria. Included were 62 OSA male patients (AHI > 10), of whom 6 had an MI history. In both control (n = 56) and MI groups (n = 6), 18 cephalometric parameters were traced. Data were analyzed using independent samples t-test.
Results:
Compared with control OSA patients, OSA patients with MI showed a significantly larger tongue length (p = 0.015). The other cephalometric variables were not significantly different between the two groups.
Conclusion:
An elongated tongue might be considered a risk factor for MI in OSA patients. The role of other variables remains inconclusive and open to investigation with larger samples (determined based on pilot studies such as this report) collected in longitudinal fashion.
More Related Videos
Related Concept Videos
Sleep Apnea
The condition is more prevalent among...
Coronary Artery Disease I: Introduction
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Insufficient Sleep and Sleep Deprivation
Sleep deprivation is a more severe form of sleep loss...
Physical Assessment of the Respiratory Tract II: Inspection
Chest Configuration
The chest configuration...
Coronary Artery Disease III: Clinical Manifestations

